Medtech Products Inc., the company behind Clear Eyes, voluntarily recalled about 39,060 bottles of its Maximum Itchy Eye Relief drops on July 29, 2026. The company could not guarantee the product was free of contamination. The Food and Drug Administration classified the recall as Class II on August 14, 2026. No injuries, infections or deaths tied to the recalled lot have been publicly reported so far.
Key facts
- Recalled product: Clear Eyes Maximum Itchy Eye Relief, 0.5-fluid-ounce (15 mL) dropper bottles
- Affected lot: 2552A, expiring September 30, 2027
- Volume: about 39,060 bottles, shipped nationwide
- Recalled by: Medtech Products Inc., a subsidiary of Prestige Consumer Healthcare (Tarrytown, New York)
- Recall issued: July 29, 2026
- FDA classification: Class II, assigned August 14, 2026
- Reason: “lack of assurance of sterility” — no contaminant has been named
- Reported injuries: none publicly reported so far
What was recalled
Only one batch is covered: Clear Eyes Maximum Itchy Eye Relief in 0.5-fluid-ounce (15 mL) dropper bottles, lot 2552A, expiring September 30, 2027. Medtech is a subsidiary of Prestige Consumer Healthcare, based in Tarrytown, New York, and it shipped these bottles nationwide. No other Clear Eyes product or lot has been named in the recall; if the numbers on your bottle don’t match, this recall does not apply to it.
Why Medtech issued the recall
The company cited a “lack of assurance of sterility” — it could not confirm the drops were free of contamination — without naming what, if anything, was actually found inside.
What to do if you have this product
- Compare the lot number and expiration date on your bottle against lot 2552A, expiring September 30, 2027.
- If they match, stop using the product.
- Return the bottle to where you bought it for a refund.
- If you’ve already used drops from that lot and have concerns, a pharmacist or doctor can help.
How serious is a Class II recall
Class II means the product may cause temporary or medically reversible adverse health consequences, while the probability of serious adverse health consequences is considered remote.
Other eye-drop recalls in 2026
This is not the only eye-drop recall of 2026, though none of the others are connected to it:
- K.C. Pharmaceuticals: more than 3 million bottles of store-brand lubricating drops, pulled in the spring
- Lupin: roughly 2.5 million bottles of prescription prednisolone acetate drops, recalled in June over a foreign substance
- Rohto-Mentholatum: close to 12 million cartons of Cooling Eye Drops, pulled in July
Three different manufacturers, three different products — nothing in the reporting ties any of them to the Clear Eyes recall.
Not connected to the 2023 EzriCare outbreak
The Clear Eyes recall is also separate from the 2023 crisis linked to EzriCare and Delsam Pharma artificial tears, which involved a drug-resistant bacteria strain and was tied to reported deaths and vision loss. That outbreak involved different manufacturers and a confirmed contaminant. The available reporting does not link the Clear Eyes recall to that earlier outbreak.
Legal action so far
No lawsuits over the Clear Eyes recall have been confirmed as filed; one personal-injury law firm says it is investigating potential claims, which is not the same as a filed suit.